Electrotherapy Systems Global Market Report 2024

The electrotherapy systems market size has grown strongly in recent years. It will grow from $4.55 billion in 2023 to $4.96 billion in 2024 at a compound annual growth rate (CAGR) of 9%. The expansion observed in the historical period can be attributed to several factors, including the increasing prevalence of spinal injuries resulting from accidents, growth in the aging population, rising health expenditures, escalating incidences of back pain and neck pain, and a growing focus on non-invasive therapeutic approaches.

The electrotherapy systems market size is expected to see strong growth in the next few years. It will grow to $7.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing approval of electrotherapy systems, a strong emphasis on chronic pain management, rising healthcare expenditures supporting the adoption of electrotherapy systems, a focus on personalized pain relief solutions for chronic conditions, and increasing awareness and acceptance of electrotherapy systems among patients and healthcare providers. Major trends expected in this period include technological advancements in electrotherapy systems, the launch of innovative products, approval of breakthrough devices by regulatory bodies, regulatory approvals for new electrotherapy technologies, and a heightened focus on pain management in high-contact sports such as football, rugby, and wrestling.

The anticipated rise in spinal and sports injuries is poised to drive the growth of the electrotherapy systems market in the foreseeable future. Spinal and sports injuries, encompassing trauma to the spinal cord and surrounding tissues, are increasingly prevalent due to factors such as heightened participation in rigorous physical activities and intensified competitive sports, coupled with inadequate preventive measures. Electrotherapy systems play a crucial role in managing spinal and sports injuries by offering targeted pain relief, muscle rehabilitation, and tissue healing through non-invasive treatment modalities. A report from the New Zealand Spinal Trust in October 2022 indicated a notable increase in sports and recreational spinal cord injuries, underscoring the growing incidence of such injuries. Additionally, data from the National Library of Medicine in May 2022 highlighted the significant global burden of spinal cord injuries, further emphasizing the demand for effective treatment solutions. As such, the escalating prevalence of spinal and sports injuries is a key driver fueling the expansion of the electrotherapy systems market.

Leading companies in the electrotherapy systems market are concentrating on innovation to stay competitive and address evolving consumer demands. Next-generation electrotherapy technologies, characterized by targeted electrical stimulation for pain management, rehabilitation, and neurological disorders, offer enhanced efficacy, precision, and patient comfort. For example, Enovis introduced cutting-edge electrotherapy systems, Intelect Legend 2 and Intelect Transport 2, in April 2023. These systems deliver increased muscular contractions, minimize patient discomfort, and reduce neural fatigue, offering therapists an intuitive user interface for streamlined treatment settings selection. Such advancements in electrotherapy technology cater to the growing demand for effective and patient-friendly treatment modalities, driving innovation in the market.

In March 2021, in a strategic move to strengthen its market position and expand its portfolio, Bioventus acquired Bioness Inc. This acquisition underscores Bioventus's commitment to enhancing its neurorehabilitation device and therapy offerings, leveraging Bioness's expertise in providing electrotherapy solutions. Bioness Inc., renowned for its functional electrical stimulation (FES) systems, robotic systems, and software-based therapy programs, aligns with Bioventus's strategic objectives of diversification and growth in the electrotherapy systems market. Through strategic acquisitions and portfolio expansions, companies such as Bioventus aim to capitalize on the burgeoning demand for electrotherapy solutions and address the evolving needs of healthcare providers and patients alike.

Major companies operating in the electrotherapy systems market are Abbott Laboratories, Phoenix Healthcare Group, Medtronic PLC, Boston Scientific Corporation, Omron Healthcare Inc., St. Jude Medical Inc., DJO Global LLC, LivaNova PLC, BTL Industries LLC, Beurer GmbH, Nevro Corporation, Cyberonics Inc., Zynex Inc., Dynatronics Corporation, Uroplasty Inc., North Coast Medical Inc., PureCare by Fabrictech, NeuroMetrix Inc., TensCare Ltd., Cionic Inc., EMS Physio Ltd., STYMCO Medical, Neuro20 Technologies Corp., Eme srl.

North America was the largest region in the electrotherapy systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electrotherapy systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the electrotherapy systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Electrotherapy systems are medical devices designed to alleviate pain, facilitate healing, and enhance muscular function through the application of controlled electrical stimulation. By delivering targeted electrical impulses to specific areas of the body, these devices offer therapeutic benefits for a range of medical conditions.

The primary technologies utilized in electrotherapy systems encompass transcutaneous electrical nerve stimulation (TENS), neuromuscular electrical stimulation (NMES), inferential current (IFC), percutaneous electrical nerve stimulation (PENS), electronic muscle stimulator (EMS), spinal cord stimulation (SCS), electro-acupuncture (EA), and others. Transcutaneous electrical nerve stimulation (TENS) involves non-invasive therapy that employs electrical stimulation to mitigate pain by targeting nerves through the skin. Electrotherapy systems find applications in various medical fields including chronic wound healing, neuromuscular dysfunction, pain management, tissue repair, musculoskeletal disorders, physical therapy, iontophoresis, and others. These systems are utilized by diverse end-users such as clinics, hospitals, long-term care centers, rehabilitation centers, and others.

The electrotherapy systems research report is one of a series of new reports that provides electrotherapy systems market statistics, including the electrotherapy systems industry's global market size, regional shares, competitors with an electrotherapy systems market share, detailed electrotherapy systems market segments, market trends and opportunities, and any further data you may need to thrive in the electrotherapy systems industry. This electrotherapy systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The electrotherapy systems market consists of revenues earned by entities providing services such as ultrasound therapy, microcurrent therapy, and high-voltage pulsed current therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The electrotherapy systems market also includes sales of galvanic stimulation devices, high-frequency electrical stimulation devices, and microcurrent therapy devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.